Montserrat Domènech

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Journal of Clinical Oncology · 2011 · 127 citations · Full text

The R71G<i>BRCA1</i>is a founder Spanish mutation and leads to aberrant splicing of the transcript

Ana Vega, Berta Campos, Brigitte Bressac–de Paillerets et al. · Human Mutation · 2001 · 118 citations · Full text

Genetics, Rna Splicing, Genetic Epidemiology +18

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 69 citations · Full text

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +7

BRCA2 germ-line mutations in Spanish male breast cancer patients

J. Mancebo Cortés, Montserrat Domènech, Carles Pericay et al. · Annals of Oncology · 2000 · 50 citations

Brca2 Germ-line Mutations, Breast Oncology, Pathology +4

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

Jesús García-Donás, Albert Font, Begoña Pérez‐Valderrama et al. · The Lancet Oncology · 2017 · 50 citations

Urology, Genitourinary Cancer, Medicine +6